These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8403679

  • 1. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T, Katayama S, Tanaka E, Yamamura Y, Nakamura S.
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [Abstract] [Full Text] [Related]

  • 2. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
    Kohriyama T, Tanaka E, Katayama S, Yamamura Y, Nakamura S.
    Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
    [Abstract] [Full Text] [Related]

  • 3. Von Willebrand factor in diabetic angiopathy.
    Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [Abstract] [Full Text] [Related]

  • 4. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy.
    Nozaki H, Hiramatsu K, Arimori S.
    Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682
    [Abstract] [Full Text] [Related]

  • 5. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):138-43. PubMed ID: 6084321
    [Abstract] [Full Text] [Related]

  • 6. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
    Kessler L, Wiesel ML, Boudjema K, Lutun E, Moulin B, Cazenave JP, Wolf P, Pinget M.
    Clin Transplant; 1998 Feb 31; 12(1):35-42. PubMed ID: 9541421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coagulation in diabetic and non-diabetic claudicants.
    Gosk-Bierska I, Adamiec R, Alexewicz P, Wysokinski WE.
    Int Angiol; 2002 Jun 31; 21(2):128-33. PubMed ID: 12110772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov 31; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

  • 11. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.
    Blood Coagul Fibrinolysis; 2009 Mar 31; 20(2):89-100. PubMed ID: 19786936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun 31; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 16. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 31; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 17. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
    Nossent AY, VAN Marion V, VAN Tilburg NH, Rosendaal FR, Bertina RM, VAN Mourik JA, Eikenboom HC.
    J Thromb Haemost; 2006 Dec 31; 4(12):2556-62. PubMed ID: 17059421
    [Abstract] [Full Text] [Related]

  • 18. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M, Ricchetti I, La Selva M, Bertagna A, Molinatti GM.
    Diabetes Res; 1984 Nov 31; 1(4):219-21. PubMed ID: 6442228
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ.
    Thromb Haemost; 1997 Jun 31; 77(6):1104-8. PubMed ID: 9241740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.